DVA Medical Fee Schedule Tracker

Showing 5301–5350 of 5886 Pg 107/118

	Item No.	Description	Category	MBS Fee	DVA Fee
	73446	Characterisation of a variant or variants in a panel of at least 25 genes using DNA and RNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse	Category 6 — Pathology	$1100.00	$1100.00
Item Number 73446 Fee Comparison MBS $1100.00 → DVA $1100.00 Additional DVA Rates Pathology Fee $1100.00 Full Description Characterisation of a variant or variants in a panel of at least 25 genes using DNA and RNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse Sign in to watch this code → Get an email alert when this item changes
	73447	Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of myeloid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse	Category 6 — Pathology	$927.90	$927.90
Item Number 73447 Fee Comparison MBS $927.90 → DVA $927.90 Additional DVA Rates Pathology Fee $927.90 Full Description Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of myeloid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse Sign in to watch this code → Get an email alert when this item changes
	73448	Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse	Category 6 — Pathology	$927.90	$927.90
Item Number 73448 Fee Comparison MBS $927.90 → DVA $927.90 Additional DVA Rates Pathology Fee $927.90 Full Description Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse Sign in to watch this code → Get an email alert when this item changes
	73451	Testing of a patient (who is pregnant or planning pregnancy) to identify carrier status for pathogenic or likely pathogenic variants in a gene mentioned in paragraph (a), (b) or (c), to determine: (a) for the cystic fibrosis transmembrane conductance regulator (CFTR) gene—reproductive risk of cystic fibrosis; (b) for the survival motor neuron 1 (SMN1) gene—reproductive risk of spinal muscular atrophy; (c) for the fragile X messenger ribonucleoprotein 1 (FMR1) gene—reproductive risk of fragile X syndrome; (other than a service associated with a service to which item 73300, 73305, 73345, 73346, 73347, 73348, 73349 or 73350 applies) One test per lifetime	Category 6 — Pathology	$400.00	$400.00
Item Number 73451 Fee Comparison MBS $400.00 → DVA $400.00 Additional DVA Rates Pathology Fee $400.00 Full Description Testing of a patient (who is pregnant or planning pregnancy) to identify carrier status for pathogenic or likely pathogenic variants in a gene mentioned in paragraph (a), (b) or (c), to determine: (a) for the cystic fibrosis transmembrane conductance regulator (CFTR) gene—reproductive risk of cystic fibrosis; (b) for the survival motor neuron 1 (SMN1) gene—reproductive risk of spinal muscular atrophy; (c) for the fragile X messenger ribonucleoprotein 1 (FMR1) gene—reproductive risk of fragile X syndrome; (other than a service associated with a service to which item 73300, 73305, 73345, 73346, 73347, 73348, 73349 or 73350 applies) One test per lifetime Sign in to watch this code → Get an email alert when this item changes
	73452	Testing of the reproductive partner of a patient who has been found to be a carrier of a pathogenic or likely pathogenic variant in the CFTR or SMN1 gene identified by testing under item 73451, for the purpose of determining the couple’s reproductive risk of cystic fibrosis or spinal muscular atrophy One test per condition per lifetime	Category 6 — Pathology	$400.00	$400.00
Item Number 73452 Fee Comparison MBS $400.00 → DVA $400.00 Additional DVA Rates Pathology Fee $400.00 Full Description Testing of the reproductive partner of a patient who has been found to be a carrier of a pathogenic or likely pathogenic variant in the CFTR or SMN1 gene identified by testing under item 73451, for the purpose of determining the couple’s reproductive risk of cystic fibrosis or spinal muscular atrophy One test per condition per lifetime Sign in to watch this code → Get an email alert when this item changes
	73453	Characterisation of germline pathogenic or likely pathogenic gene variants: (a) in at least the following genes: (i) ASPA; (ii) BLM; (iii) CFTR; (iv) ELP1; (v) FANCA; (vi) FANCC; (vii) FANCG; (viii) FMR1; (ix) G6PC1; (x) GBA1; (xi) HEXA; (xii) MCOLN1; (xiii) SLC37A4; (xiv) SMN1; (xv) SMPD1; and (b) in a patient of reproductive age who is of Ashkenazi Jewish descent for the purpose of ascertaining the patient’s carrier status for the following: (i) Bloom syndrome (ii) Canavan disease (iii) Cystic fibrosis (iv) Familial dysautonomia (v) Fanconi anaemia type C (vi) Fragile-X syndrome (vii) Gaucher disease (viii) Glycogen storage disease type I (ix) Mucolipidosis type IV (x) Niemann-Pick disease type A 7 (xi) Spinal muscular atrophy (xii) Tay-Sachs disease Applicable once per lifetime	Category 6 — Pathology	$425.00	$425.00
Item Number 73453 Fee Comparison MBS $425.00 → DVA $425.00 Additional DVA Rates Pathology Fee $425.00 Full Description Characterisation of germline pathogenic or likely pathogenic gene variants: (a) in at least the following genes: (i) ASPA; (ii) BLM; (iii) CFTR; (iv) ELP1; (v) FANCA; (vi) FANCC; (vii) FANCG; (viii) FMR1; (ix) G6PC1; (x) GBA1; (xi) HEXA; (xii) MCOLN1; (xiii) SLC37A4; (xiv) SMN1; (xv) SMPD1; and (b) in a patient of reproductive age who is of Ashkenazi Jewish descent for the purpose of ascertaining the patient’s carrier status for the following: (i) Bloom syndrome (ii) Canavan disease (iii) Cystic fibrosis (iv) Familial dysautonomia (v) Fanconi anaemia type C (vi) Fragile-X syndrome (vii) Gaucher disease (viii) Glycogen storage disease type I (ix) Mucolipidosis type IV (x) Niemann-Pick disease type A 7 (xi) Spinal muscular atrophy (xii) Tay-Sachs disease Applicable once per lifetime Sign in to watch this code → Get an email alert when this item changes
	73454	Whole gene sequencing of a gene or genes described in item 73453, in a patient who is the reproductive partner of an individual who is affected by, or is a known genetic carrier of, one or more conditions described in item 73453 (other than cystic fibrosis, fragile‑X syndrome or spinal muscular atrophy), for the purpose of determining the couple’s combined reproductive risk of the conditions, if: (a) the patient is not eligible for a service to which item 73453 applies; and (b) the patient has not received a service to which item 73453 applies; and (c) the patient has not received a service to which this item applies for the purpose of determining the patient’s reproductive risk with the patient’s current reproductive partner Applicable once per couple per lifetime	Category 6 — Pathology	$1200.00	$1200.00
Item Number 73454 Fee Comparison MBS $1200.00 → DVA $1200.00 Additional DVA Rates Pathology Fee $1200.00 Full Description Whole gene sequencing of a gene or genes described in item 73453, in a patient who is the reproductive partner of an individual who is affected by, or is a known genetic carrier of, one or more conditions described in item 73453 (other than cystic fibrosis, fragile‑X syndrome or spinal muscular atrophy), for the purpose of determining the couple’s combined reproductive risk of the conditions, if: (a) the patient is not eligible for a service to which item 73453 applies; and (b) the patient has not received a service to which item 73453 applies; and (c) the patient has not received a service to which this item applies for the purpose of determining the patient’s reproductive risk with the patient’s current reproductive partner Applicable once per couple per lifetime Sign in to watch this code → Get an email alert when this item changes
	73455	Testing of a pregnant patient, if at least one prospective parent is known to be affected by, or is a genetic carrier of, one or more conditions described in item 73453, for the purpose of determining whether a familial variant or variants are present in the fetus, if: (a) the testing is requested by a specialist or consultant physician; and (b) there is at least a 25% risk of the fetus inheriting a condition described in paragraph (b) of item 73453	Category 6 — Pathology	$1600.00	$1600.00
Item Number 73455 Fee Comparison MBS $1600.00 → DVA $1600.00 Additional DVA Rates Pathology Fee $1600.00 Full Description Testing of a pregnant patient, if at least one prospective parent is known to be affected by, or is a genetic carrier of, one or more conditions described in item 73453, for the purpose of determining whether a familial variant or variants are present in the fetus, if: (a) the testing is requested by a specialist or consultant physician; and (b) there is at least a 25% risk of the fetus inheriting a condition described in paragraph (b) of item 73453 Sign in to watch this code → Get an email alert when this item changes
	73456	Characterisation by whole genome sequencing, or by either or both whole exome sequencing and mitochondrial DNA sequencing, of germline variants present in nuclear DNA and in mitochondrial DNA of a patient with a strong suspicion of a mitochondrial disease, if: (a) the characterisation is requested by a specialist or consultant physician; and (b) the characterisation is requested because of the onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or “failure to thrive” in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease, or any of the above; and (c) the service is not a service associated with a service to which item 73358, 73359 or 73457 applies Applicable only once per lifetime	Category 6 — Pathology	$2100.00	$2100.00
Item Number 73456 Fee Comparison MBS $2100.00 → DVA $2100.00 Additional DVA Rates Pathology Fee $2100.00 Full Description Characterisation by whole genome sequencing, or by either or both whole exome sequencing and mitochondrial DNA sequencing, of germline variants present in nuclear DNA and in mitochondrial DNA of a patient with a strong suspicion of a mitochondrial disease, if: (a) the characterisation is requested by a specialist or consultant physician; and (b) the characterisation is requested because of the onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or “failure to thrive” in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease, or any of the above; and (c) the service is not a service associated with a service to which item 73358, 73359 or 73457 applies Applicable only once per lifetime Sign in to watch this code → Get an email alert when this item changes
	73457	Characterisation by whole genome sequencing, or either or both whole exome sequencing and mitochondrial DNA sequencing, of germline variants present in nuclear DNA and in mitochondrial DNA, of a patient with a strong suspicion of a mitochondrial disease, if: (a) the characterisation is performed using a sample from the patient and a sample from each of the patient’s biological parents; and (b) the request for the characterisation states that singleton testing is inappropriate; and (c) the characterisation is requested by a specialist or consultant physician; and (d) the characterisation is requested because of the onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or “failure to thrive” in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease; and (e) the service is not a service associated with a service to which item 73358, 73359 or 73456 applies Applicable only once per lifetime	Category 6 — Pathology	$3300.00	$3300.00
Item Number 73457 Fee Comparison MBS $3300.00 → DVA $3300.00 Additional DVA Rates Pathology Fee $3300.00 Full Description Characterisation by whole genome sequencing, or either or both whole exome sequencing and mitochondrial DNA sequencing, of germline variants present in nuclear DNA and in mitochondrial DNA, of a patient with a strong suspicion of a mitochondrial disease, if: (a) the characterisation is performed using a sample from the patient and a sample from each of the patient’s biological parents; and (b) the request for the characterisation states that singleton testing is inappropriate; and (c) the characterisation is requested by a specialist or consultant physician; and (d) the characterisation is requested because of the onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or “failure to thrive” in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease; and (e) the service is not a service associated with a service to which item 73358, 73359 or 73456 applies Applicable only once per lifetime Sign in to watch this code → Get an email alert when this item changes
	73458	Re-analysis of whole genome or whole exome or mitochondrial DNA data obtained in performing a service to which item 73456 or 73457 applies, for characterisation of previously unreported germline variants related to the clinical phenotype, if: (a) the re-analysis is requested by a specialist or consultant physician; and (b) the patient is strongly suspected of having a monogenic mitochondrial disease; and (c) the re-analysis is performed at least 24 months after: (i) the service to which item 73456 or 73457 applies; or (ii) a service to which this item applies Applicable twice per lifetime	Category 6 — Pathology	$500.00	$500.00
Item Number 73458 Fee Comparison MBS $500.00 → DVA $500.00 Additional DVA Rates Pathology Fee $500.00 Full Description Re-analysis of whole genome or whole exome or mitochondrial DNA data obtained in performing a service to which item 73456 or 73457 applies, for characterisation of previously unreported germline variants related to the clinical phenotype, if: (a) the re-analysis is requested by a specialist or consultant physician; and (b) the patient is strongly suspected of having a monogenic mitochondrial disease; and (c) the re-analysis is performed at least 24 months after: (i) the service to which item 73456 or 73457 applies; or (ii) a service to which this item applies Applicable twice per lifetime Sign in to watch this code → Get an email alert when this item changes
	73459	Testing for diagnostic purposes of a pregnant patient, for detection in the fetus of a gene variant or variants present in the parents, if: (a) the gene variant or variants are: (i) a variant or variants in the mitochondrial genome identified in the oocyte donating parent; or (ii) autosomal recessive variants identified in both biological parents within the same gene; or (iii) an autosomal dominant or X-linked variant identified in either biological parent; or (iv) identified in a biological sibling of the fetus; and (b) the causative variant or variants for the condition of the fetus’ first-degree relative have been confirmed by laboratory findings; and (c) the detection is requested by a specialist or consultant physician; and (d) the service is not a service associated with a service to which item 73361, 73362, 73363 or 73462 applies	Category 6 — Pathology	$1600.00	$1600.00
Item Number 73459 Fee Comparison MBS $1600.00 → DVA $1600.00 Additional DVA Rates Pathology Fee $1600.00 Full Description Testing for diagnostic purposes of a pregnant patient, for detection in the fetus of a gene variant or variants present in the parents, if: (a) the gene variant or variants are: (i) a variant or variants in the mitochondrial genome identified in the oocyte donating parent; or (ii) autosomal recessive variants identified in both biological parents within the same gene; or (iii) an autosomal dominant or X-linked variant identified in either biological parent; or (iv) identified in a biological sibling of the fetus; and (b) the causative variant or variants for the condition of the fetus’ first-degree relative have been confirmed by laboratory findings; and (c) the detection is requested by a specialist or consultant physician; and (d) the service is not a service associated with a service to which item 73361, 73362, 73363 or 73462 applies Sign in to watch this code → Get an email alert when this item changes
	73460	Characterisation of mitochondrial DNA deletion or variant for diagnostic purposes in a patient suspected to have mitochondrial disease, if: (a) the characterisation is requested by the specialist or consultant physician managing the patient’s treatment; and (b) the patient displays onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or ‘failure to thrive’ in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease; and (c) the service is performed following a service to which items 73292, 73358, 73359, 73456 or 73457 applies for the same patient if the results were non-informativeApplicable 3 times per lifetime	Category 6 — Pathology	$450.00	$450.00
Item Number 73460 Fee Comparison MBS $450.00 → DVA $450.00 Additional DVA Rates Pathology Fee $450.00 Full Description Characterisation of mitochondrial DNA deletion or variant for diagnostic purposes in a patient suspected to have mitochondrial disease, if: (a) the characterisation is requested by the specialist or consultant physician managing the patient’s treatment; and (b) the patient displays onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or ‘failure to thrive’ in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease; and (c) the service is performed following a service to which items 73292, 73358, 73359, 73456 or 73457 applies for the same patient if the results were non-informativeApplicable 3 times per lifetime Sign in to watch this code → Get an email alert when this item changes
	73461	Whole gene testing of a person for the characterisation of all germline gene variants within the same gene in which the person’s reproductive partner has a pathogenic or likely pathogenic germline recessive gene variant for mitochondrial disease, if: (a) the partner’s germline recessive gene variant is confirmed by laboratory findings; and (b) the characterisation is requested by a specialist or consultant physician	Category 6 — Pathology	$1200.00	$1200.00
Item Number 73461 Fee Comparison MBS $1200.00 → DVA $1200.00 Additional DVA Rates Pathology Fee $1200.00 Full Description Whole gene testing of a person for the characterisation of all germline gene variants within the same gene in which the person’s reproductive partner has a pathogenic or likely pathogenic germline recessive gene variant for mitochondrial disease, if: (a) the partner’s germline recessive gene variant is confirmed by laboratory findings; and (b) the characterisation is requested by a specialist or consultant physician Sign in to watch this code → Get an email alert when this item changes
	73462	Testing of a person for the detection of a single gene variant, if: (a) the person tested has a biological relative with a known pathogenic or likely pathogenic mitochondrial disease variant confirmed by laboratory findings; and (b) the testing is requested by a specialist or consultant physician; and (c) the service is not a service associated with a service to which item 73361, 73362 or 73363 applies	Category 6 — Pathology	$400.00	$400.00
Item Number 73462 Fee Comparison MBS $400.00 → DVA $400.00 Additional DVA Rates Pathology Fee $400.00 Full Description Testing of a person for the detection of a single gene variant, if: (a) the person tested has a biological relative with a known pathogenic or likely pathogenic mitochondrial disease variant confirmed by laboratory findings; and (b) the testing is requested by a specialist or consultant physician; and (c) the service is not a service associated with a service to which item 73361, 73362 or 73363 applies Sign in to watch this code → Get an email alert when this item changes
	73521	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test)	Category 6 — Pathology	$10.20	$9.95 ▼
Item Number 73521 Fee Comparison MBS $10.20 → DVA $9.95 -$0.25 (-2%) Additional DVA Rates Pathology Fee $9.95 Full Description Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test) Sign in to watch this code → Get an email alert when this item changes
	73523	Semen examination (other than post-vasectomy semen examination), including: (a) measurement of volume, sperm count and motility; and (b) examination of stained preparations; and (c) morphology; and (if performed) (d) differential count and 1 or more chemical tests; (Item is subject to rule 25)	Category 6 — Pathology	$43.85	$42.75 ▼
Item Number 73523 Fee Comparison MBS $43.85 → DVA $42.75 -$1.10 (-3%) Additional DVA Rates Pathology Fee $42.75 Full Description Semen examination (other than post-vasectomy semen examination), including: (a) measurement of volume, sperm count and motility; and (b) examination of stained preparations; and (c) morphology; and (if performed) (d) differential count and 1 or more chemical tests; (Item is subject to rule 25) Sign in to watch this code → Get an email alert when this item changes
	73525	Sperm antibodies - sperm-penetrating ability - 1 or more tests	Category 6 — Pathology	$29.80	$29.05 ▼
Item Number 73525 Fee Comparison MBS $29.80 → DVA $29.05 -$0.75 (-3%) Additional DVA Rates Pathology Fee $29.05 Full Description Sperm antibodies - sperm-penetrating ability - 1 or more tests Sign in to watch this code → Get an email alert when this item changes
	73527	Human chorionic gonadotrophin (HCG) - detection in serum or urine by 1 or more methods for diagnosis of pregnancy - 1 or more tests	Category 6 — Pathology	$10.50	$10.25 ▼
Item Number 73527 Fee Comparison MBS $10.50 → DVA $10.25 -$0.25 (-2%) Additional DVA Rates Pathology Fee $10.25 Full Description Human chorionic gonadotrophin (HCG) - detection in serum or urine by 1 or more methods for diagnosis of pregnancy - 1 or more tests Sign in to watch this code → Get an email alert when this item changes
	73529	Human chorionic gonadotrophin (HCG), quantitation in serum by 1 or more methods (except by latex, membrane, strip or other pregnancy test kit) for diagnosis of threatened abortion, or follow up of abortion or diagnosis of ectopic pregnancy, including any services performed in item 73527 - 1 test	Category 6 — Pathology	$30.10	$29.35 ▼
Item Number 73529 Fee Comparison MBS $30.10 → DVA $29.35 -$0.75 (-2%) Additional DVA Rates Pathology Fee $29.35 Full Description Human chorionic gonadotrophin (HCG), quantitation in serum by 1 or more methods (except by latex, membrane, strip or other pregnancy test kit) for diagnosis of threatened abortion, or follow up of abortion or diagnosis of ectopic pregnancy, including any services performed in item 73527 - 1 test Sign in to watch this code → Get an email alert when this item changes
	73801	Semen examination for presence of spermatozoa	Category 6 — Pathology	$6.90	$6.90
Item Number 73801 Fee Comparison MBS $6.90 → DVA $6.90 Additional DVA Rates Pathology Fee $6.90 Full Description Semen examination for presence of spermatozoa Sign in to watch this code → Get an email alert when this item changes
	73802	Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count - 1 test	Category 6 — Pathology	$4.55	$4.55
Item Number 73802 Fee Comparison MBS $4.55 → DVA $4.55 Additional DVA Rates Pathology Fee $4.55 Full Description Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count - 1 test Sign in to watch this code → Get an email alert when this item changes
	73803	2 tests described in item 73802	Category 6 — Pathology	$6.35	$6.35
Item Number 73803 Fee Comparison MBS $6.35 → DVA $6.35 Additional DVA Rates Pathology Fee $6.35 Full Description 2 tests described in item 73802 Sign in to watch this code → Get an email alert when this item changes
	73804	3 or more tests described in item 73802	Category 6 — Pathology	$8.15	$8.15
Item Number 73804 Fee Comparison MBS $8.15 → DVA $8.15 Additional DVA Rates Pathology Fee $8.15 Full Description 3 or more tests described in item 73802 Sign in to watch this code → Get an email alert when this item changes
	73805	Microscopy of urine, excluding dipstick testing.	Category 6 — Pathology	$4.55	$4.55
Item Number 73805 Fee Comparison MBS $4.55 → DVA $4.55 Additional DVA Rates Pathology Fee $4.55 Full Description Microscopy of urine, excluding dipstick testing. Sign in to watch this code → Get an email alert when this item changes
	73806	Pregnancy test by 1 or more immunochemical methods	Category 6 — Pathology	$10.15	$10.15
Item Number 73806 Fee Comparison MBS $10.15 → DVA $10.15 Additional DVA Rates Pathology Fee $10.15 Full Description Pregnancy test by 1 or more immunochemical methods Sign in to watch this code → Get an email alert when this item changes
	73807	Microscopy for wet film other than urine, including any relevant stain	Category 6 — Pathology	$6.90	$6.90
Item Number 73807 Fee Comparison MBS $6.90 → DVA $6.90 Additional DVA Rates Pathology Fee $6.90 Full Description Microscopy for wet film other than urine, including any relevant stain Sign in to watch this code → Get an email alert when this item changes
	73808	Microscopy of Gram-stained film, including (if performed) a service described in item 73805 or 73807	Category 6 — Pathology	$8.65	$8.65
Item Number 73808 Fee Comparison MBS $8.65 → DVA $8.65 Additional DVA Rates Pathology Fee $8.65 Full Description Microscopy of Gram-stained film, including (if performed) a service described in item 73805 or 73807 Sign in to watch this code → Get an email alert when this item changes
	73809	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method	Category 6 — Pathology	$2.35	$2.35
Item Number 73809 Fee Comparison MBS $2.35 → DVA $2.35 Additional DVA Rates Pathology Fee $2.35 Full Description Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method Sign in to watch this code → Get an email alert when this item changes
	73810	Microscopy for fungi in skin, hair or nails - 1 or more sites	Category 6 — Pathology	$6.90	$6.90
Item Number 73810 Fee Comparison MBS $6.90 → DVA $6.90 Additional DVA Rates Pathology Fee $6.90 Full Description Microscopy for fungi in skin, hair or nails - 1 or more sites Sign in to watch this code → Get an email alert when this item changes
	73811	Mantoux test	Category 6 — Pathology	$11.20	$11.20
Item Number 73811 Fee Comparison MBS $11.20 → DVA $11.20 Additional DVA Rates Pathology Fee $11.20 Full Description Mantoux test Sign in to watch this code → Get an email alert when this item changes
	73812	Quantitation of glycated haemoglobin (HbA1c) performed in the management of established diabetes, if performed: (a) as a point‑of‑care test; and (b) by or on behalf of a medical practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point‑of-care testing under the National General Practice Accreditation Scheme; and (c) using a method certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrumentation used has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%) Applicable not more than 3 times per 12 months per patient	Category 6 — Pathology	$11.80	$11.80
Item Number 73812 Fee Comparison MBS $11.80 → DVA $11.80 Additional DVA Rates Pathology Fee $11.80 Full Description Quantitation of glycated haemoglobin (HbA1c) performed in the management of established diabetes, if performed: (a) as a point‑of‑care test; and (b) by or on behalf of a medical practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point‑of-care testing under the National General Practice Accreditation Scheme; and (c) using a method certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrumentation used has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%) Applicable not more than 3 times per 12 months per patient Sign in to watch this code → Get an email alert when this item changes
	73813	Detection performed by, or on behalf of, a medical practitioner of: (a) chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) via molecular point-of-care testing for the diagnosis of CT or NG infection; and (b) trichomonas vaginalis (TV) via molecular point-of-care testing for the diagnosis of TV infection	Category 6 — Pathology	$117.65	$117.65
Item Number 73813 Fee Comparison MBS $117.65 → DVA $117.65 Additional DVA Rates Pathology Fee $117.65 Full Description Detection performed by, or on behalf of, a medical practitioner of: (a) chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) via molecular point-of-care testing for the diagnosis of CT or NG infection; and (b) trichomonas vaginalis (TV) via molecular point-of-care testing for the diagnosis of TV infection Sign in to watch this code → Get an email alert when this item changes
	73825	Detection performed by a participating nurse practitioner of: (a) chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) via molecular point-of-care testing for the diagnosis of CT or NG infection; and (b) trichomonas vaginalis (TV) via molecular point-of-care testing for the diagnosis of TV infection	Category 6 — Pathology	$117.65	$117.65
Item Number 73825 Fee Comparison MBS $117.65 → DVA $117.65 Additional DVA Rates Pathology Fee $117.65 Full Description Detection performed by a participating nurse practitioner of: (a) chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) via molecular point-of-care testing for the diagnosis of CT or NG infection; and (b) trichomonas vaginalis (TV) via molecular point-of-care testing for the diagnosis of TV infection Sign in to watch this code → Get an email alert when this item changes
	73826	Quantitation of glycated haemoglobin (HbA1c) performed by a participating nurse practitioner in the management of established diabetes when performed: (a) as a point‑of‑care test; (b) by a nurse practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point-of-care testing under the National General Practice Accreditation Scheme; and (c) using a method and instrument certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrument has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%) Applicable not more than 3 times per 12 months per patient	Category 6 — Pathology	$11.80	$11.80
Item Number 73826 Fee Comparison MBS $11.80 → DVA $11.80 Additional DVA Rates Pathology Fee $11.80 Full Description Quantitation of glycated haemoglobin (HbA1c) performed by a participating nurse practitioner in the management of established diabetes when performed: (a) as a point‑of‑care test; (b) by a nurse practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point-of-care testing under the National General Practice Accreditation Scheme; and (c) using a method and instrument certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrument has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%) Applicable not more than 3 times per 12 months per patient Sign in to watch this code → Get an email alert when this item changes
	73828	Semen examination for presence of spermatozoa by a participating nurse practitioner	Category 6 — Pathology	$6.90	$6.90
Item Number 73828 Fee Comparison MBS $6.90 → DVA $6.90 Additional DVA Rates Pathology Fee $6.90 Full Description Semen examination for presence of spermatozoa by a participating nurse practitioner Sign in to watch this code → Get an email alert when this item changes
	73829	Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count by a participating nurse practitioner - 1 test	Category 6 — Pathology	$4.55	$4.55
Item Number 73829 Fee Comparison MBS $4.55 → DVA $4.55 Additional DVA Rates Pathology Fee $4.55 Full Description Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count by a participating nurse practitioner - 1 test Sign in to watch this code → Get an email alert when this item changes
	73830	2 tests described in item 73829 by a participating nurse practitioner	Category 6 — Pathology	$6.35	$6.35
Item Number 73830 Fee Comparison MBS $6.35 → DVA $6.35 Additional DVA Rates Pathology Fee $6.35 Full Description 2 tests described in item 73829 by a participating nurse practitioner Sign in to watch this code → Get an email alert when this item changes
	73831	3 or more tests described in item 73829 by a participating nurse practitioner	Category 6 — Pathology	$8.15	$8.15
Item Number 73831 Fee Comparison MBS $8.15 → DVA $8.15 Additional DVA Rates Pathology Fee $8.15 Full Description 3 or more tests described in item 73829 by a participating nurse practitioner Sign in to watch this code → Get an email alert when this item changes
	73832	Microscopy of urine, excluding dipstick testing by a participating nurse practitioner.	Category 6 — Pathology	$4.55	$4.55
Item Number 73832 Fee Comparison MBS $4.55 → DVA $4.55 Additional DVA Rates Pathology Fee $4.55 Full Description Microscopy of urine, excluding dipstick testing by a participating nurse practitioner. Sign in to watch this code → Get an email alert when this item changes
	73833	Pregnancy test by 1 or more immunochemical methods by a participating nurse practitioner	Category 6 — Pathology	$10.15	$10.15
Item Number 73833 Fee Comparison MBS $10.15 → DVA $10.15 Additional DVA Rates Pathology Fee $10.15 Full Description Pregnancy test by 1 or more immunochemical methods by a participating nurse practitioner Sign in to watch this code → Get an email alert when this item changes
	73834	Microscopy for wet film other than urine, including any relevant stain by a participating nurse practitioner	Category 6 — Pathology	$6.90	$6.90
Item Number 73834 Fee Comparison MBS $6.90 → DVA $6.90 Additional DVA Rates Pathology Fee $6.90 Full Description Microscopy for wet film other than urine, including any relevant stain by a participating nurse practitioner Sign in to watch this code → Get an email alert when this item changes
	73835	Microscopy of Gram-stained film, including (if performed) a service described in item 73832 or 73834 by a participating nurse practitioner	Category 6 — Pathology	$8.65	$8.65
Item Number 73835 Fee Comparison MBS $8.65 → DVA $8.65 Additional DVA Rates Pathology Fee $8.65 Full Description Microscopy of Gram-stained film, including (if performed) a service described in item 73832 or 73834 by a participating nurse practitioner Sign in to watch this code → Get an email alert when this item changes
	73836	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method by a participating nurse practitioner	Category 6 — Pathology	$2.35	$2.35
Item Number 73836 Fee Comparison MBS $2.35 → DVA $2.35 Additional DVA Rates Pathology Fee $2.35 Full Description Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method by a participating nurse practitioner Sign in to watch this code → Get an email alert when this item changes
	73837	Microscopy for fungi in skin, hair or nails by a participating nurse practitioner - 1 or more sites	Category 6 — Pathology	$6.90	$6.90
Item Number 73837 Fee Comparison MBS $6.90 → DVA $6.90 Additional DVA Rates Pathology Fee $6.90 Full Description Microscopy for fungi in skin, hair or nails by a participating nurse practitioner - 1 or more sites Sign in to watch this code → Get an email alert when this item changes
	73839	Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk - not more than once in a 12 month period.	Category 6 — Pathology	$16.80	$16.80
Item Number 73839 Fee Comparison MBS $16.80 → DVA $16.80 Additional DVA Rates Pathology Fee $16.80 Full Description Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk - not more than once in a 12 month period. Sign in to watch this code → Get an email alert when this item changes
	73840	Quantitation of glycosylated haemoglobin performed in the management of established diabetes – each test to a maximum of 4 tests in a 12 month period	Category 6 — Pathology	$17.00	$17.00
Item Number 73840 Fee Comparison MBS $17.00 → DVA $17.00 Additional DVA Rates Pathology Fee $17.00 Full Description Quantitation of glycosylated haemoglobin performed in the management of established diabetes – each test to a maximum of 4 tests in a 12 month period Sign in to watch this code → Get an email alert when this item changes
	73844	Quantitation of urinary albumin/creatine ratio in urine on a random spot collection in the management of patients with established diabetes or patients at risk of microalbuminuria.	Category 6 — Pathology	$20.35	$20.35
Item Number 73844 Fee Comparison MBS $20.35 → DVA $20.35 Additional DVA Rates Pathology Fee $20.35 Full Description Quantitation of urinary albumin/creatine ratio in urine on a random spot collection in the management of patients with established diabetes or patients at risk of microalbuminuria. Sign in to watch this code → Get an email alert when this item changes
	73899	Initiation of a patient episode that consists of a service described in item 72858 or 72859 in circumstances other than those mentioned in item 73900	Category 6 — Pathology	$5.95	$5.95
Item Number 73899 Fee Comparison MBS $5.95 → DVA $5.95 Additional DVA Rates Pathology Fee $5.95 Full Description Initiation of a patient episode that consists of a service described in item 72858 or 72859 in circumstances other than those mentioned in item 73900 Sign in to watch this code → Get an email alert when this item changes
	73900	Initiation of a patient episode that consists of a service described in item 72858 or 72859 if the service is rendered in a prescribed laboratory.	Category 6 — Pathology	$2.40	$2.40
Item Number 73900 Fee Comparison MBS $2.40 → DVA $2.40 Additional DVA Rates Pathology Fee $2.40 Full Description Initiation of a patient episode that consists of a service described in item 72858 or 72859 if the service is rendered in a prescribed laboratory. Sign in to watch this code → Get an email alert when this item changes

MBS Fee

$1100.00

DVA Fee

$1100.00

Category

Category 6 — Pathology

Description

Characterisation of a variant or variants in a panel of at least 25 genes using DNA and RNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse

MBS Fee

$927.90

DVA Fee

$927.90

Category

Category 6 — Pathology

Description

Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of myeloid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse

MBS Fee

$927.90

DVA Fee

$927.90

Category

Category 6 — Pathology

Description

Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse

MBS Fee

$400.00

DVA Fee

$400.00

Category

Category 6 — Pathology

Description

Testing of a patient (who is pregnant or planning pregnancy) to identify carrier status for pathogenic or likely pathogenic variants in a gene mentioned in paragraph (a), (b) or (c), to determine: (a) for the cystic fibrosis transmembrane conductance regulator (CFTR) gene—reproductive risk of cystic fibrosis; (b) for the survival motor neuron 1 (SMN1) gene—reproductive risk of spinal muscular atrophy; (c) for the fragile X messenger ribonucleoprotein 1 (FMR1) gene—reproductive risk of fragile X syndrome; (other than a service associated with a service to which item 73300, 73305, 73345, 73346, 73347, 73348, 73349 or 73350 applies) One test per lifetime

MBS Fee

$400.00

DVA Fee

$400.00

Category

Category 6 — Pathology

Description

Testing of the reproductive partner of a patient who has been found to be a carrier of a pathogenic or likely pathogenic variant in the CFTR or SMN1 gene identified by testing under item 73451, for the purpose of determining the couple’s reproductive risk of cystic fibrosis or spinal muscular atrophy One test per condition per lifetime

MBS Fee

$425.00

DVA Fee

$425.00

Category

Category 6 — Pathology

Description

Characterisation of germline pathogenic or likely pathogenic gene variants: (a) in at least the following genes: (i) ASPA; (ii) BLM; (iii) CFTR; (iv) ELP1; (v) FANCA; (vi) FANCC; (vii) FANCG; (viii) FMR1; (ix) G6PC1; (x) GBA1; (xi) HEXA; (xii) MCOLN1; (xiii) SLC37A4; (xiv) SMN1; (xv) SMPD1; and (b) in a patient of reproductive age who is of Ashkenazi Jewish descent for the purpose of ascertaining the patient’s carrier status for the following: (i) Bloom syndrome (ii) Canavan disease (iii) Cystic fibrosis (iv) Familial dysautonomia (v) Fanconi anaemia type C (vi) Fragile-X syndrome (vii) Gaucher disease (viii) Glycogen storage disease type I (ix) Mucolipidosis type IV (x) Niemann-Pick disease type A 7 (xi) Spinal muscular atrophy (xii) Tay-Sachs disease Applicable once per lifetime

MBS Fee

$1200.00

DVA Fee

$1200.00

Category

Category 6 — Pathology

Description

Whole gene sequencing of a gene or genes described in item 73453, in a patient who is the reproductive partner of an individual who is affected by, or is a known genetic carrier of, one or more conditions described in item 73453 (other than cystic fibrosis, fragile‑X syndrome or spinal muscular atrophy), for the purpose of determining the couple’s combined reproductive risk of the conditions, if: (a) the patient is not eligible for a service to which item 73453 applies; and (b) the patient has not received a service to which item 73453 applies; and (c) the patient has not received a service to which this item applies for the purpose of determining the patient’s reproductive risk with the patient’s current reproductive partner Applicable once per couple per lifetime

MBS Fee

$1600.00

DVA Fee

$1600.00

Category

Category 6 — Pathology

Description

Testing of a pregnant patient, if at least one prospective parent is known to be affected by, or is a genetic carrier of, one or more conditions described in item 73453, for the purpose of determining whether a familial variant or variants are present in the fetus, if: (a) the testing is requested by a specialist or consultant physician; and (b) there is at least a 25% risk of the fetus inheriting a condition described in paragraph (b) of item 73453

MBS Fee

$2100.00

DVA Fee

$2100.00

Category

Category 6 — Pathology

Description

Characterisation by whole genome sequencing, or by either or both whole exome sequencing and mitochondrial DNA sequencing, of germline variants present in nuclear DNA and in mitochondrial DNA of a patient with a strong suspicion of a mitochondrial disease, if: (a) the characterisation is requested by a specialist or consultant physician; and (b) the characterisation is requested because of the onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or “failure to thrive” in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease, or any of the above; and (c) the service is not a service associated with a service to which item 73358, 73359 or 73457 applies Applicable only once per lifetime

MBS Fee

$3300.00

DVA Fee

$3300.00

Category

Category 6 — Pathology

Description

Characterisation by whole genome sequencing, or either or both whole exome sequencing and mitochondrial DNA sequencing, of germline variants present in nuclear DNA and in mitochondrial DNA, of a patient with a strong suspicion of a mitochondrial disease, if: (a) the characterisation is performed using a sample from the patient and a sample from each of the patient’s biological parents; and (b) the request for the characterisation states that singleton testing is inappropriate; and (c) the characterisation is requested by a specialist or consultant physician; and (d) the characterisation is requested because of the onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or “failure to thrive” in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease; and (e) the service is not a service associated with a service to which item 73358, 73359 or 73456 applies Applicable only once per lifetime

MBS Fee

$500.00

DVA Fee

$500.00

Category

Category 6 — Pathology

Description

Re-analysis of whole genome or whole exome or mitochondrial DNA data obtained in performing a service to which item 73456 or 73457 applies, for characterisation of previously unreported germline variants related to the clinical phenotype, if: (a) the re-analysis is requested by a specialist or consultant physician; and (b) the patient is strongly suspected of having a monogenic mitochondrial disease; and (c) the re-analysis is performed at least 24 months after: (i) the service to which item 73456 or 73457 applies; or (ii) a service to which this item applies Applicable twice per lifetime

MBS Fee

$1600.00

DVA Fee

$1600.00

Category

Category 6 — Pathology

Description

Testing for diagnostic purposes of a pregnant patient, for detection in the fetus of a gene variant or variants present in the parents, if: (a) the gene variant or variants are: (i) a variant or variants in the mitochondrial genome identified in the oocyte donating parent; or (ii) autosomal recessive variants identified in both biological parents within the same gene; or (iii) an autosomal dominant or X-linked variant identified in either biological parent; or (iv) identified in a biological sibling of the fetus; and (b) the causative variant or variants for the condition of the fetus’ first-degree relative have been confirmed by laboratory findings; and (c) the detection is requested by a specialist or consultant physician; and (d) the service is not a service associated with a service to which item 73361, 73362, 73363 or 73462 applies

MBS Fee

$450.00

DVA Fee

$450.00

Category

Category 6 — Pathology

Description

Characterisation of mitochondrial DNA deletion or variant for diagnostic purposes in a patient suspected to have mitochondrial disease, if: (a) the characterisation is requested by the specialist or consultant physician managing the patient’s treatment; and (b) the patient displays onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or ‘failure to thrive’ in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease; and (c) the service is performed following a service to which items 73292, 73358, 73359, 73456 or 73457 applies for the same patient if the results were non-informativeApplicable 3 times per lifetime

MBS Fee

$1200.00

DVA Fee

$1200.00

Category

Category 6 — Pathology

Description

Whole gene testing of a person for the characterisation of all germline gene variants within the same gene in which the person’s reproductive partner has a pathogenic or likely pathogenic germline recessive gene variant for mitochondrial disease, if: (a) the partner’s germline recessive gene variant is confirmed by laboratory findings; and (b) the characterisation is requested by a specialist or consultant physician

MBS Fee

$400.00

DVA Fee

$400.00

Category

Category 6 — Pathology

Description

Testing of a person for the detection of a single gene variant, if: (a) the person tested has a biological relative with a known pathogenic or likely pathogenic mitochondrial disease variant confirmed by laboratory findings; and (b) the testing is requested by a specialist or consultant physician; and (c) the service is not a service associated with a service to which item 73361, 73362 or 73363 applies

MBS Fee

$10.20

DVA Fee

$9.95

Category

Category 6 — Pathology

Description

Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test)

MBS Fee

$43.85

DVA Fee

$42.75

Category

Category 6 — Pathology

Description

Semen examination (other than post-vasectomy semen examination), including: (a) measurement of volume, sperm count and motility; and (b) examination of stained preparations; and (c) morphology; and (if performed) (d) differential count and 1 or more chemical tests; (Item is subject to rule 25)

MBS Fee

$29.80

DVA Fee

$29.05

Category

Category 6 — Pathology

Description

Sperm antibodies - sperm-penetrating ability - 1 or more tests

MBS Fee

$10.50

DVA Fee

$10.25

Category

Category 6 — Pathology

Description

Human chorionic gonadotrophin (HCG) - detection in serum or urine by 1 or more methods for diagnosis of pregnancy - 1 or more tests

MBS Fee

$30.10

DVA Fee

$29.35

Category

Category 6 — Pathology

Description

Human chorionic gonadotrophin (HCG), quantitation in serum by 1 or more methods (except by latex, membrane, strip or other pregnancy test kit) for diagnosis of threatened abortion, or follow up of abortion or diagnosis of ectopic pregnancy, including any services performed in item 73527 - 1 test

MBS Fee

$6.90

DVA Fee

$6.90

Category

Category 6 — Pathology

Description

Semen examination for presence of spermatozoa

MBS Fee

$4.55

DVA Fee

$4.55

Category

Category 6 — Pathology

Description

Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count - 1 test

MBS Fee

$6.35

DVA Fee

$6.35

Category

Category 6 — Pathology

Description

2 tests described in item 73802

MBS Fee

$8.15

DVA Fee

$8.15

Category

Category 6 — Pathology

Description

3 or more tests described in item 73802

MBS Fee

$4.55

DVA Fee

$4.55

Category

Category 6 — Pathology

Description

Microscopy of urine, excluding dipstick testing.

MBS Fee

$10.15

DVA Fee

$10.15

Category

Category 6 — Pathology

Description

Pregnancy test by 1 or more immunochemical methods

MBS Fee

$6.90

DVA Fee

$6.90

Category

Category 6 — Pathology

Description

Microscopy for wet film other than urine, including any relevant stain

MBS Fee

$8.65

DVA Fee

$8.65

Category

Category 6 — Pathology

Description

Microscopy of Gram-stained film, including (if performed) a service described in item 73805 or 73807

MBS Fee

$2.35

DVA Fee

$2.35

Category

Category 6 — Pathology

Description

Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method

MBS Fee

$6.90

DVA Fee

$6.90

Category

Category 6 — Pathology

Description

Microscopy for fungi in skin, hair or nails - 1 or more sites

MBS Fee

$11.20

DVA Fee

$11.20

Category

Category 6 — Pathology

Description

Mantoux test

MBS Fee

$11.80

DVA Fee

$11.80

Category

Category 6 — Pathology

Description

Quantitation of glycated haemoglobin (HbA1c) performed in the management of established diabetes, if performed: (a) as a point‑of‑care test; and (b) by or on behalf of a medical practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point‑of-care testing under the National General Practice Accreditation Scheme; and (c) using a method certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrumentation used has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%) Applicable not more than 3 times per 12 months per patient

MBS Fee

$117.65

DVA Fee

$117.65

Category

Category 6 — Pathology

Description

Detection performed by, or on behalf of, a medical practitioner of: (a) chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) via molecular point-of-care testing for the diagnosis of CT or NG infection; and (b) trichomonas vaginalis (TV) via molecular point-of-care testing for the diagnosis of TV infection

MBS Fee

$117.65

DVA Fee

$117.65

Category

Category 6 — Pathology

Description

Detection performed by a participating nurse practitioner of: (a) chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) via molecular point-of-care testing for the diagnosis of CT or NG infection; and (b) trichomonas vaginalis (TV) via molecular point-of-care testing for the diagnosis of TV infection

MBS Fee

$11.80

DVA Fee

$11.80

Category

Category 6 — Pathology

Description

Quantitation of glycated haemoglobin (HbA1c) performed by a participating nurse practitioner in the management of established diabetes when performed: (a) as a point‑of‑care test; (b) by a nurse practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point-of-care testing under the National General Practice Accreditation Scheme; and (c) using a method and instrument certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrument has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%) Applicable not more than 3 times per 12 months per patient

MBS Fee

$6.90

DVA Fee

$6.90

Category

Category 6 — Pathology

Description

Semen examination for presence of spermatozoa by a participating nurse practitioner

MBS Fee

$4.55

DVA Fee

$4.55

Category

Category 6 — Pathology

Description

Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count by a participating nurse practitioner - 1 test

MBS Fee

$6.35

DVA Fee

$6.35

Category

Category 6 — Pathology

Description

2 tests described in item 73829 by a participating nurse practitioner

MBS Fee

$8.15

DVA Fee

$8.15

Category

Category 6 — Pathology

Description

3 or more tests described in item 73829 by a participating nurse practitioner

MBS Fee

$4.55

DVA Fee

$4.55

Category

Category 6 — Pathology

Description

Microscopy of urine, excluding dipstick testing by a participating nurse practitioner.

MBS Fee

$10.15

DVA Fee

$10.15

Category

Category 6 — Pathology

Description

Pregnancy test by 1 or more immunochemical methods by a participating nurse practitioner

MBS Fee

$6.90

DVA Fee

$6.90

Category

Category 6 — Pathology

Description

Microscopy for wet film other than urine, including any relevant stain by a participating nurse practitioner

MBS Fee

$8.65

DVA Fee

$8.65

Category

Category 6 — Pathology

Description

Microscopy of Gram-stained film, including (if performed) a service described in item 73832 or 73834 by a participating nurse practitioner

MBS Fee

$2.35

DVA Fee

$2.35

Category

Category 6 — Pathology

Description

Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method by a participating nurse practitioner

MBS Fee

$6.90

DVA Fee

$6.90

Category

Category 6 — Pathology

Description

Microscopy for fungi in skin, hair or nails by a participating nurse practitioner - 1 or more sites

MBS Fee

$16.80

DVA Fee

$16.80

Category

Category 6 — Pathology

Description

Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk - not more than once in a 12 month period.

MBS Fee

$17.00

DVA Fee

$17.00

Category

Category 6 — Pathology

Description

Quantitation of glycosylated haemoglobin performed in the management of established diabetes – each test to a maximum of 4 tests in a 12 month period

MBS Fee

$20.35

DVA Fee

$20.35

Category

Category 6 — Pathology

Description

Quantitation of urinary albumin/creatine ratio in urine on a random spot collection in the management of patients with established diabetes or patients at risk of microalbuminuria.

MBS Fee

$5.95

DVA Fee

$5.95

Category

Category 6 — Pathology

Description

Initiation of a patient episode that consists of a service described in item 72858 or 72859 in circumstances other than those mentioned in item 73900

MBS Fee

$2.40

DVA Fee

$2.40

Category

Category 6 — Pathology

Description

Initiation of a patient episode that consists of a service described in item 72858 or 72859 if the service is rendered in a prescribed laboratory.

← Prev 105 106 107 108 109 Next →

50 items per page · tap/click any row to expand